Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:22

RNS Number : 0199K
Softcat PLC
05 April 2018
 

Softcat plc (the "Company")

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities

 

 

The following notification relates to the award of nil-cost options to person discharging managerial responsibilities ("PDMR") on 4 April 2018 under the Softcat plc Long Term Incentive Plan ("LTIP").  

 

Softcat plc Long Term Incentive Plan

 

On 4 April 2018, an award of nil-cost options to acquire 66,864 shares was made to Graeme Watt, a director and PDMR. The number of shares over which the nil-cost option was awarded has been calculated by reference to the closing middle market quotation of the ordinary shares derived from the Daily Official List on the dealing day preceding the date of grant (6.73 pence). The award will vest subject to the performance conditions outlined below.

 

 

Performance Conditions and Vesting of Awards

 

These nil-cost options are subject to the rules of the LTIP and will vest depending on performance against Total Shareholder Return ("TSR") and Earnings per Share ("EPS") targets as measured over a three year performance period.

 

50% of the Award will be subject to the Company's relative TSR performance against the FTSE 250 (excluding real estate and investment trusts):

 

TSR performance % of Award vesting

Below median Nil

At median 30%

Upper quartile or above 100%

 

50% of the Award will be subject to the Company's EPS for FY 2020:

 

EPS Growth % of Award vesting

Less than 23.7 pence Nil

23.7 pence 20%

26.9 pence or above 100%

 

There will be straight line vesting between the points as outlined above.

 

The normal date of vesting for the nil-cost options outlined above will be 4 April 2021 and the last date for exercise will be 3 April 2028, with dividend equivalents payable in respect of the vesting of nil-cost options in accordance with the rules of the LTIP.

 

For further information on the LTIP, please refer to the Company's Annual Report and Accounts.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Graeme Watt

 

2.

Reason for the notification

a)

Position / status

Chief Executive

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Softcat plc

b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of £0.0005 each

 

 

ISIN: GB00BYZDVK82

b)

Nature of the transaction

Grant of nil cost option over Ordinary Shares of £0.0005 each under the Softcat plc Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.00

66,864

d)

Aggregated information

Aggregated volume

Price

 

N/A

e)

Date of the transaction

 

2018-04-04

f)

Place of the transaction

 

Outside a trading venue

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGGDKKGGRZM
Date   Source Headline
13th Jan 20265:29 pmRNSTransaction in Own Shares
12th Jan 20265:33 pmRNSTransaction in Own Shares
9th Jan 20266:21 pmRNSTransaction in Own Shares
8th Jan 20266:31 pmRNSTransaction in Own Shares
8th Jan 20262:03 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSShare Buyback Programme
2nd Jan 202610:21 amRNSTotal Voting Rights
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
16th Dec 20251:15 pmRNSResult of AGM
15th Dec 20254:02 pmRNSDirector/PDMR Shareholding
12th Dec 20251:06 pmRNSDirector/PDMR Shareholding
10th Dec 202511:18 amRNSDirector/PDMR Shareholding
10th Dec 202511:09 amRNSDirector/PDMR Shareholding
28th Nov 20251:47 pmRNSDirector/PDMR Shareholding
28th Nov 20251:41 pmRNSDirector/PDMR Shareholding
25th Nov 202510:43 amRNSAdditional Listing
18th Nov 20257:00 amRNSQ1 2026 Trading Update
13th Nov 202511:04 amRNSBlock listing Interim Review
11th Nov 20252:29 pmRNSDirector/PDMR Shareholding
5th Nov 20251:15 pmRNSAnnual Financial Report
3rd Nov 20252:37 pmRNSTotal Voting Rights
22nd Oct 20257:00 amRNSPreliminary Results
9th Oct 20252:48 pmRNSDirector/PDMR Shareholding
23rd Sep 202510:57 amRNSHolding(s) in Company
9th Sep 20251:46 pmRNSDirector/PDMR Shareholding
28th Aug 20257:00 amRNSYear End Trading Update
11th Aug 20258:48 amRNSDirector/PDMR Shareholding
9th Jul 20259:24 amRNSDirector/PDMR Shareholding
1st Jul 20259:21 amRNSTotal Voting Rights
10th Jun 20253:07 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:30 pmRNSTotal Voting Rights
28th May 20257:00 amRNSQ3 2025 Trading Update
27th May 20259:14 amRNSDirector Declaration
15th May 20259:39 amRNSBlock listing Interim Review
9th May 202512:58 pmRNSDirector/PDMR Shareholding
1st May 20253:41 pmRNSTotal Voting Rights
8th Apr 20252:46 pmRNSDirector/PDMR Shareholding
7th Apr 20259:00 amRNSAcquisition of Oakland Group Services Ltd
1st Apr 202511:35 amRNSTotal Voting Rights
19th Mar 20257:00 amRNSHalf-year Report
13th Mar 20259:52 amRNSHolding(s) in Company
10th Mar 20252:13 pmRNSDirector/PDMR Shareholding
3rd Mar 202510:41 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSNotice of Results
10th Feb 20252:37 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20251:55 pmRNSDirector/PDMR Shareholding
20th Jan 20259:34 amRNSHolding(s) in Company
17th Jan 20253:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.